NCT05482568 2023-10-16A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung CancerJiangsu HengRui Medicine Co., Ltd.Phase 1/2 Unknown324 enrolled